Voyager Therapeutics, Inc. (NASDAQ:VYGR) has 122 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 5,568,381 | -49,984 | -0.89% | $21,493,950.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 3,500,000 | -500,000 | -12.50% | $13,510,000.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 3,428,571 | 1,547,811 | 82.30% | $13,234,284.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 3,002,936 | 1,527,936 | 103.59% | $11,591,333.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,283,253 | 2,283,253 | 0.00% | $8,813,357.00 |
| Opaleye Management Inc. | 31 Mar, 2026 | 1,150,000 | -1,243,808 | -51.96% | $4,439,000.00 |
| Erste Asset Management GmbH | 31 Mar, 2026 | 1,095,141 | -100,000 | -8.37% | $4,238,196.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,049,978 | -85,210 | -7.51% | $4,054,437.00 |
| State Street Corp | 31 Mar, 2026 | 948,226 | 11,960 | 1.28% | $3,660,152.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 875,568 | -208,931 | -19.27% | $3,379,735.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 725,769 | 725,769 | 0.00% | $2,801,468.00 |
| Morgan Stanley | 31 Mar, 2026 | 681,711 | 137,597 | 25.29% | $2,631,404.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 615,660 | 392,947 | 176.44% | $2,376,448.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 578,024 | 281,574 | 94.98% | $2,231,173.00 |
| SPHERA FUNDS MANAGEMENT LTD. | 31 Mar, 2026 | 469,761 | 130,000 | 38.26% | $1,813,277.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 427,597 | -178,669 | -29.47% | $1,650,524.00 |
| DIADEMA PARTNERS LP | 31 Mar, 2026 | 423,642 | 423,642 | 0.00% | $1,635,258.00 |
| Northern Trust Corp | 31 Mar, 2026 | 384,843 | 16,297 | 4.42% | $1,485,494.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 364,664 | -191,982 | -34.49% | $1,407,603.00 |
| FIDUCIARY TRUST CO | 31 Mar, 2026 | 334,397 | 0 | 0.00% | $1,290,772.00 |